
News from Healio
Top Healio News

Health(MedPage Today) -- Patients taking GLP-1 agonists for weight loss had a small but significantly lower risk of developing cancer, a large retrospective cohort study showed.
With follow-up ranging from 1 to 11 years, use of GLP-1 agonists, such...See the Story
Good News on GLP-1s and Cancer Risk, With One Exception
67% Center coverage: 3 sources